Literature DB >> 23085365

Reduced antibody responses against Plasmodium falciparum vaccine candidate antigens in the presence of Trichuris trichiura.

Meral Esen1, Benjamin Mordmüller, Pablo Martinez de Salazar, Ayola Akim Adegnika, Selidji Todagbe Agnandji, Frieder Schaumburg, Aurore Bouyoukou Hounkpatin, Sina Brückner, Michael Theisen, Sabine Bélard, Ulysse Ateba Ngoa, Saadou Issifou, Maria Yazdanbakhsh, Peter G Kremsner.   

Abstract

BACKGROUND: Helminth infections are highly prevalent in the tropics and may have an effect on immune responses to vaccines due to their immunomodulatory effect. The prevalence of helminth infections in young children, the target group for malaria and most other vaccines, is high. Therefore we assessed the influence of helminth infection on vaccine-induced immune responses in a phase I clinical trial of the malaria vaccine candidate GMZ2.
METHODS: Twenty Gabonese preschool-age children were vaccinated with GMZ2, a blood stage malaria vaccine candidate. Humoral immune response against the vaccine antigens and parasitological status were assessed. Vaccine-specific antibody concentrations and memory B-cell numbers were compared in worm infected and non-infected participants.
RESULTS: Antibody response to GMZ2 was 3.4-fold (95% confidence interval: 1.6, 7.4) higher in Trichuris trichiura negative subjects compared to positive participants, whereas immunoglobulin subclass distribution was similar. Memory B-cell response was moderately increased in T. trichiura negative individuals, although the difference was not significant.
CONCLUSIONS: Future malaria vaccine development programs need to account for worm-mediated hyporesponsiveness of immune reactions.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085365     DOI: 10.1016/j.vaccine.2012.10.026

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  25 in total

1.  Community deworming alleviates geohelminth-induced immune hyporesponsiveness.

Authors:  Linda J Wammes; Firdaus Hamid; Aprilianto Eddy Wiria; Linda May; Maria M M Kaisar; Margaretta A Prasetyani-Gieseler; Yenny Djuardi; Heri Wibowo; Yvonne C M Kruize; Jaco J Verweij; Sanne E de Jong; Roula Tsonaka; Jeanine J Houwing-Duistermaat; Erliyani Sartono; Adrian J F Luty; Taniawati Supali; Maria Yazdanbakhsh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

2.  Chemokine levels and parasite- and allergen-specific antibody responses in children and adults with severe or uncomplicated Plasmodium falciparum malaria.

Authors:  B Wangala; A Vovor; R G Gantin; Y F Agbeko; C J Lechner; X Huang; P T Soboslay; C Köhler
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

3.  Evaluation of antibody serology to determine current helminth and Plasmodium falciparum infections in a co-endemic area in Southern Mozambique.

Authors:  Rebeca Santano; Rocío Rubio; Berta Grau-Pujol; Valdemiro Escola; Osvaldo Muchisse; Inocência Cuamba; Marta Vidal; Gemma Ruiz-Olalla; Ruth Aguilar; Javier Gandasegui; Maria Demontis; Jose Carlos Jamine; Anélsio Cossa; Charfudin Sacoor; Jorge Cano; Luis Izquierdo; Chetan E Chitnis; Ross L Coppel; Virander Chauhan; David Cavanagh; Sheetij Dutta; Evelina Angov; Lisette van Lieshout; Bin Zhan; José Muñoz; Carlota Dobaño; Gemma Moncunill
Journal:  PLoS Negl Trop Dis       Date:  2022-06-21

4.  Randomized, controlled, assessor-blind clinical trial to assess the efficacy of single- versus repeated-dose albendazole to treat ascaris lumbricoides, trichuris trichiura, and hookworm infection.

Authors:  Ayola A Adegnika; Jeannot F Zinsou; Saadou Issifou; Ulysse Ateba-Ngoa; Roland F Kassa; Eliane N Feugap; Yabo J Honkpehedji; Jean-Claude Dejon Agobe; Hilaire M Kenguele; Marguerite Massinga-Loembe; Selidji T Agnandji; Benjamin Mordmüller; Michael Ramharter; Maria Yazdanbakhsh; Peter G Kremsner; Bertrand Lell
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

5.  Effect of Antihelminthic Treatment on Vaccine Immunogenicity to a Seasonal Influenza Vaccine in Primary School Children in Gabon: A Randomized Placebo-Controlled Trial.

Authors:  Sina Brückner; Selidji T Agnandji; Stefan Berberich; Emmanuel Bache; José F Fernandes; Brunhilde Schweiger; Marguerite Massinga Loembe; Thomas Engleitner; Bertrand Lell; Benjamin Mordmüller; Ayola A Adegnika; Maria Yazdanbakhsh; Peter G Kremsner; Meral Esen
Journal:  PLoS Negl Trop Dis       Date:  2015-06-08

6.  Nematode-induced interference with vaccination efficacy targets follicular T helper cell induction and is preserved after termination of infection.

Authors:  Irma Haben; Wiebke Hartmann; Minka Breloer
Journal:  PLoS Negl Trop Dis       Date:  2014-09-25

Review 7.  Chronic Immune Activation and CD4+ T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy.

Authors:  Dawit Wolday; Francis M Ndungu; Gloria P Gómez-Pérez; Tobias F Rinke de Wit
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

8.  Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36.

Authors:  Nirianne Marie Q Palacpac; Edward Ntege; Adoke Yeka; Betty Balikagala; Nahoko Suzuki; Hiroki Shirai; Masanori Yagi; Kazuya Ito; Wakaba Fukushima; Yoshio Hirota; Christopher Nsereko; Takuya Okada; Bernard N Kanoi; Kohhei Tetsutani; Nobuko Arisue; Sawako Itagaki; Takahiro Tougan; Ken J Ishii; Shigeharu Ueda; Thomas G Egwang; Toshihiro Horii
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

9.  Oesophagostomum dentatum extract modulates T cell-dependent immune responses to bystander antigens and prevents the development of allergy in mice.

Authors:  Irma Schabussova; Onisa Ul-Haq; Elisabeth Hoflehner; Johnnie Akgün; Angelika Wagner; Gerhard Loupal; Anja Joachim; Bärbel Ruttkowski; Rick M Maizels; Ursula Wiedermann
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

10.  Impact of Helminth Infection on the Clinical and Microbiological Presentation of Chagas Diseases in Chronically Infected Patients.

Authors:  Fernando Salvador; Elena Sulleiro; Adrián Sánchez-Montalvá; Mónica Martínez-Gallo; Eugenia Carrillo; Israel Molina
Journal:  PLoS Negl Trop Dis       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.